BTCC
/
BTCC Square
/
Global Cryptocurrency
/
Cathie Wood’s ARK Invest Shifts Focus: Bullish on Biotech, Bearish on DraftKings
Cathie Wood’s ARK Invest Shifts Focus: Bullish on Biotech, Bearish on DraftKings
10
1
BTCCSquare news:
ARK Invest executed significant portfolio adjustments on August 29, 2025, doubling down on gene-editing pioneer Intellia Therapeutics while continuing its exit from DraftKings. The $1.54 million NTLA purchase extends a week-long accumulation streak as the biotech firm's shares surge 65% quarterly.
Market sentiment mirrors Wood's conviction, with TipRanks analysts maintaining a Strong Buy rating for Intellia. The MOVE underscores ARK's thematic focus on healthcare disruption, particularly in rare disease treatments using CRISPR technology.
By:
